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The lack of the desired success in using traditional
treatment protocols for ischemic and reperfusional brain
diseases leads to the need for the exact mechanisms of
pathogenesis to be identified. The vast majority of post-
ischemic brain conditions are accompanied by oxidative
stress [1, 9]. Nitric oxide (NO), which has radical proper-
ties, plays an important role in supporting the homeostasis
of brain tissue and in the pathogenesis of many brain dis-
eases, including ischemic and reperfusional conditions [7].
Sources of active forms of oxygen and NO in ischemia/re-
perfusion may include neurocytes as well as extraneuronal
structures (endothelial cells of brain vessels, glia, and
leukocytes), these making up the nitrergic system [9, 16].
The roles of NO in mediating oxidative stress in
ischemic and reperfusional lesions of various organs and
especially the brain are multilateral and different in nature.
The cytotoxic effects of NO are associated with its prooxi-
dant properties, while NO can also be an antioxidant [22].
NO hyperproduction and the resulting increase in the activ-
ity of oxidative processes represent an important patho-
genetic mechanism in brain lesions in this pathology [16].
At the same time, NO deficiency can also lead to activation
of oxidative processes. The development of pathogenetic
treatment aimed at the NO-dependent mechanisms support-
ing the homeostasis of brain tissue requires a detailed
understanding of the role of NO in maintaining the prooxi-
dant-antioxidant equilibrium in ischemic and reperfusional
brain damage. The aim of the present work was to evaluate
the level of oxidative stress in the rat brain during ischemia
and reperfusion in conditions of correction of the L-argi-
nine-NO system.
METHODS
Studies of measures characterizing oxidative processes
were performed in 128 white mongrel male rats weighing
220–250 g; brain ischemia/reperfusion was modeled by
30-min bilateral occlusion of the common carotid arteries
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The aim of the present work was to evaluate oxidative stress in the brains of rats during ischemia/reperfu-
sion in conditions of correction of the L-arginine-NO system. Experiments on 128 rats with brain
ischemia/perfusion in conditions of modulation of the L-arginine-NO system were used to study changes
in the concentrations of (a) lipid peroxidation products, i.e., diene conjugates, malonic dialdehyde, and
Schiff bases, and (b) antioxidant protection factors, i.e., retinol, α-tocopherol, and SH-groups.
Administration of L-arginine and NO synthase inhibitors, i.e., the non-selective inhibitor Nω-nitro-L-argi-
nine methyl ester, the selective neuronal NO synthase inhibitor 7-nitroindasole, and the selective inhibitor
of inducible NO synthase S-methylisothiourea, established that oxidative stress in rats with brain
ischemia/perfusion is NO-dependent. NO formed by the various isoforms of NO synthase had different
roles: hyperactivation of neuronal NO synthase was responsible for oxidative stress in both periods of brain
ischemia/reperfusion, while increased inducible NO synthase activity was responsible in the late period.
KEY WORDS: brain, ischemia/reperfusion, oxidative stress, nitric oxide.
Department of Pathophysiology, Department of Normal
Physiology, Grodno State Medical University,
80 Gor’kii, 230015 Grodno, Belarus.Ре
по
зи
то
ри
й Г
рГ
М
У
with subsequent 30-min (the early period) or 24-h (the late
period) reperfusion [13], after which brain tissue was col-
lected in liquid nitrogen until studies were performed.
These time points were selected on the basis of the time dif-
ferences in the activation of different isoforms of NO syn-
thase. Thus, the activity of constitutional NO synthase iso-
forms (endothelial NO synthase and neuronal NO synthase)
increases quickly in ischemia, while the activity of
inducible NO synthase increases at 6–12 h, reaching a peak
by 24 h [12].
Modulation of the L-arginine-NO system was achieved
by treatment with the NO substrate L-arginine and inhibitors
of various NO synthases: the non-selective NO synthase
inhibitor Nω-nitro-L-arginine methyl ester (L-NAME,
Sigma), the selective neuronal NO synthase inhibitor
7-nitroindasole (7-NI, Sigma), and the selective inhibitor of
inducible NO synthase S-methylisothiourea (S-MT, Sigma).
Animals were divided into eight groups (n = 16), each of
which was divided into two subgroups (n = 8 in each). Rats of
group 1 (sham-operated control 1) received i.v. isotonic NaCl
(0.5 ml). Rats of groups 2–8 underwent modeling of brain
ischemia/reperfusion. Rats of group 2 received i.v. isotonic
saline (0.5 ml). Rats of groups 3–8 received i.v. doses of mod-
ulators of the L-arginine-NO system: group 3 received L-argi-
nine (150 mg/kg), group 4 received L-NAME (5 mg/kg),
group 5 received 7-NI (10 mg/kg), group 6 received S-MT
(1 mg/kg), group 7 received 7-NI and S-MT, and group 8
received 7-NI, S-MT, and L-arginine at the same doses.
Agents were given immediately after occlusion of the com-
mon carotid arteries. Experiments were performed in condi-
tions of i.v. thiopental anesthesia (40–60 µg/kg).
The extent of oxidative stress in brain homogenates
was assessed by measuring the concentrations of lipid per-
oxidation products: diene conjugates, malonic dialdehyde,
and Schiff bases; the concentrations of antioxidant protec-
tion factors were also measured, i.e., retinol, α-tocopherol,
and SH groups. The concentrations of lipid peroxidation
products were measured by classical methods: diene conju-
gates using an SF-46 spectrophotometer (originated in
Russia) [4], malonic dialdehyde on a Specord (Germany)
spectrophotometer [15], and Schiff bases using an F-4010
(Hitachi, Japan) spectrophotometer [19]. The concentra-
tions of antioxidant protection factors were measured using
a Specord (Germany) spectrophotometer for SH groups
[21] and an F-4010 (Hitachi, Japan) spectrophotometer for
retinol and α-tocopherol [8]. Data were analyzed by varia-
tion statistics using Student’s t test.
RESULTS
Measurements of lipid peroxidation products in brain
tissue from rats subjected to brain ischemia/reperfusion
(I/R) in conditions of correction of the L-arginine-NO sys-
tem in rats of group 2 (I/R, control 2) in the early period
showed significant increases in diene conjugates, malonic
dialdehyde, and Schiff bases (Table 1), with decreases in
retinol, α-tocopherol, and SH groups (Fig. 1). In the late
period of brain ischemia/reperfusion, there was a more sig-
nificant increase in Schiff bases (to 576 ± 6.2 U/g, p < 0.001)
than in the early period (p < 0.001) (Table 2), and a decrease
in retinol compared with control group 1 to 1.7 ± 0.04 nmol/g
(control: 2.5 ± 0.05 nmol/g, p < 0.001), a decrease in
α-tocopherol to 14.1 ± 0.48 nmol/g (20.1 ± 0.35 nmol/g,
p < 0.001), and a decrease in SH groups to 3.0 ± 0.06 nmol/g
(3.7 ± 0.05 nmol/g, p < 0.001). It should be noted that the
decreases in retinol and α-tocopherol concentrations in the
late period of brain ischemia-reperfusion were less signifi-
cant than those in the early period (p < 0.05). Subsequent
comparative analysis was performed between measures
from groups 3–8 and group 2 (control 2), between measures
from multiple groups, and between measures from individ-
ual groups in the early and late periods. Administration of
L-arginine to rats of group 3 led in the early period to sig-
nificant decreases in malonic dialdehyde and Schiff bases
and increases in retinol (to 2.2 ± 0.05 nmol/g, p < 0.001),
α-tocopherol (to 17.4 ± 0.35 nmol/g, p < 0.05), and SH
groups (to 3.3 ± 0.04 nmol/g, p < 0.05). In the late period,
Maksimovich, Zinchuk, and Maslakov374
TABLE 1. Lipid Peroxidation Activity in Brain Tissue in Rats During the Early Period of Brain
Ischemia/Reperfusion (I/R) after Administration of Modulators of the L-Arginine-NO System (n = 8)
Schiff bases, U/g
Notes (here and Table 2). Differences between values in the control and other groups: *p < 0.05, **p < 0.001;
differences between values in the I/R group and other groups: #p < 0.05; ##p < 0.001.
Control
I/R
L-arginine + I/R
L-NAME + I/R
7-NI + I/R
S-MT + I/R
7-NI + S-MT + I/R
7-NI + S-MT + L-arginine + I/R
Group Diene conjugates,
nmol/g
Malonic dialdehyde,
µmol/g
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there were decreases in the levels of all measures of lipid
peroxidation, i.e., diene conjugates, malonic dialdehyde,
and Schiff bases, along with increases in retinol (to 2.1 ± 0.05
nmol/g, p < 0.05), α-tocopherol (to 16.9 ± 0.32 nmol/g,
p < 0.001), and SH groups (to 3.3 ± 0.04 nmol/g, p < 0.05).
However, in the late period of brain ischemia-reperfusion,
there were significantly higher levels of diene conjugates
and Schiff bases and lower levels of retinol than in the early
period. Analysis of the results from this group provided evi-
dence for the antioxidant effects of L-arginine in both the
early and late periods of brain ischemia/reperfusion.
In rats of group 4, administration of L-NAME showed
increases in lipid peroxidation products at both periods of
brain ischemia/reperfusion, the increases in Schiff bases in
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Fig. 1. Retinol (A), α-tocopherol (B), and SH group (C) levels in brain tissue from rats with brain ischemia/reperfusion (I/R) during
modulation of the L-arginine-NO system. The vertical axes show the concentrations of retinol, nmol/g (A), α-tocopherol, nmol/g (B),
and SH groups, µmol/g (C). White columns show the early period of I/R; dark columns show the late period of I/R. 1) Control 1;
2) I/R; 3) I/R + L-arginine; 4) I/R + L-NAME; 5) I/R + 7-NI; 6) I/R + S-MT; 7) I/R + 7-NI + S-MT; 8) I/R + 7-NI + S-MT + L-argi-
nine. Differences between values in the control and other groups: *p < 0.05; **p < 0.001; differences between values in the I/R and
other groups: #p < 0.05; ##p < 0.001.
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the late period being more significant (p < 0.001). Rats in
this group also showed decreases in the concentrations of
antioxidant protection factors. During the early period,
retinol decreased to 1.6 ± 0.04 nmol/g (p < 0.001), α-toco-
pherol to 13.2 ± 0.29 nmol/g (p < 0.05), and SH groups to
2.5 ± 0.03 nmol/g (p < 0.001); in the late periods, the α-
tocopherol level decreased more significantly than in the
early period, i.e., to 12.1 ± 0.28 nmol/g (p < 0.05). Thus, in
contrast to the situation with L-arginine, rats with brain
ischemia/reperfusion given the non-selective NO synthase
inhibitor L-NAME showed increases in the level of oxida-
tive processes in brain tissue at both periods, these being
more marked in the late period of ischemia/reperfusion.
In rats of group 5, administration of the selective
inhibitor of neuronal NO synthase 7-NI led to decreases in
the concentrations of lipid peroxidation products in the
early and late periods; some measures of lipid peroxidation
– malonic dialdehyde and Schiff bases – were significantly
greater, while antioxidant protection factors – α-tocopherol
(16.3 ± 0.36 nmol/g, p < 0.001) and SH groups (3.1 ± 0.03
nmol/g, p < 0.05) – were lower than in the early period. The
nature of changes in lipid peroxidation products and antiox-
idant protection in rats of this group provide evidence that
NO formed by neuronal NO synthase has a significant role
in mediating the mechanisms of oxidative stress in the rat
brain during both periods of ischemia/reperfusion.
Comparison of lipid peroxidation and antioxidant factor
levels revealed no overall differences in the extents of the
antioxidant effects in rats given L-arginine and 7-NI.
Administration of the selective inhibitor of inducible
NO synthase S-MT (group 6) produced no changes in brain
tissue levels of lipid peroxidation products or antioxidant
protection factors in the early period of brain ische-
mia/reperfusion. However, in the late period, there were sig-
nificant decreases in diene conjugates, malonic dialdehyde,
and Schiff bases, along with increases in retinol (to 2.3 ±
± 0.06 nmol/g, p < 0.001), α-tocopherol (to 16.9 ± 0.24
nmol/g, p < 0.05), and SH groups (to 3.2 ± 0.04 nmol/g,
p < 0.05). Comparison of the effects of 7-NI and S-MT
showed more significant decreases in Schiff bases in the
brain tissues of rats given S-MT as compared with Schiff
bases in rats given 7-NI (p < 0.001). Analysis of the results
obtained from this group provided evidence for a defining
role for NO formed by inducible NO synthase in the mech-
anisms of oxidative stress in the brain tissues of rats in the
late period of brain ischemia/reperfusion.
Combined treatment of rats of group 7 with 7-NI and
S-MT led, in the late period of brain ischemia/reperfusion,
to more marked decreases in malonic dialdehyde and Schiff
bases and a more marked increase in SH groups than seen
in group 5 (7-NI); there were also more marked decreases in
diene conjugates and Schiff bases than in group 6 (S-MT),
though there were no differences in measures of lipid per-
oxidation and antioxidant protection in these groups in the
early period.
Rats of group 8, given combined 7-NI, S-MT, and
L-arginine, showed the most significant decreases in the
activity of oxidative processes. As compared with group 7
(7-NI + S-MT), there were significant decreases in diene
conjugates and malonic dialdehyde at both time points,
such that values were no different from those recorded in
control group 1. In terms of differences in antioxidant pro-
tection in the early and late periods of brain ischemia/reper-
fusion, it should be noted that differences persisted only in
relation to α-retinol, at 19.1 ± 0.24 nmol/g (p < 0.05), and
SH groups, at 3.5 ± 0.02 nmol/g (p < 0.05).
DISCUSSION
Analysis of the results shows that subtotal brain
ischemia/reperfusion in rats led to increases in the activity
of oxidative processes in brain tissues in both periods of
brain ischemia/reperfusion, though the degree of oxidative
stress in the late period was more significant. Administra-
tion of L-arginine led to decreases in the concentrations of
lipid peroxidation products and increases in the concentra-
tions of antioxidant protection factors in rat brain tissues,
with a consequent decrease in the level of oxidative stress
at both periods of brain ischemia/reperfusion. The positive
effects of L-arginine may be associated with the antiradical
and antioxidant effects of the NO formed from it, inhibi-
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TABLE 2. Lipid Peroxidation Activity in Brain Tissue in Rats During the Late Period of Brain
Ischemia/Reperfusion (I/R) after Administration of Modulators of the L-Arginine-NO System (n = 8)
Schiff bases, U/g
Control
I/R
L-arginine + I/R
L-NAME + I/R
7-NI + I/R
S-MT + I/R
7-NI + S-MT + I/R
7-NI + S-MT + L-arginine + I/R
Group Diene conjugates,
nmol/g
Malonic dialdehyde,
µmol/g
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tion of the effects of inositol-1,4,5-triphosphate, and inhi-
bition of leukocyte adhesion, and inhibition of the accu-
mulation of leukocytes in the reperfused tissue [5, 6].
Deficiency of L-arginine in brain neurons and inadequate
levels of NO formation within them lead to increases in
superoxide anion formation [20]. It has been suggested
that the antioxidant effect of L-arginine in brain ische-
mia/reperfusion may be due to activation of NO synthesis
involving endothelial NO synthase, indirect inhibition of
the activity of neuronal and inducible NO synthases as a
result of improvements in brain circulation and decreases
in the ischemic zone, as well as its direct antioxidant
action.
Administration of the selective inhibitor of nNO syn-
thase 7-NI decreased the level of oxidative stress in rat brain
tissues in the early and late periods to the same extent as
L-arginine. The mechanisms of glutamate excitotoxicity in
ischemic brain damage are linked to the increased activity
of neuronal NO synthase and the hyperproduction of NO
mediated by this enzyme [9, 16]. It is evident that the
involvement of NO formed by the neuronal isoform of NO
synthase mediates the mechanisms of oxidative stress in
reperfusional processes in the brain.
Administration of the selective inducible NO synthase
inhibitor S-MT was shown to be followed by decreases in
lipid peroxidation activity and increases in the levels of
antioxidant protection factors, predominantly in the late
period of brain ischemia/reperfusion. This provides grounds
for suggesting that NO formed by the inducible isoform of
NO synthase mediates the mechanisms of oxidative stress
in the late reperfusion period. Sources of inducible NO syn-
thase in brain tissue may include not only macrophages of
leukocyte and glial origin, but also endothelial cells [14]
and thrombocytes and neurocytes [11]. The prooxidant
action of the nitric oxide formed by neuronal and inducible
NO synthases is associated with its ability to form the
strong oxidant peroxynitrite which, like NO, can make a
significant contribution to ongoing physiological processes
in the brain. Neurodegenerative changes are facilitated by
increases in the concentrations of peroxynitrite and its prod-
ucts (hydroxyl radicals and nitrites) [10, 17].
The involvement of neuronal and inducible NO syn-
thase in the pathogenesis of oxidative stress in brain
ischemia/reperfusion is supported by experimental data
from the simultaneous use of two selective inhibitors of
neuronal NO synthase, 7-NI, and inducible NO synthase,
S-MT. During the early period of brain ischemia/reperfu-
sion, the activity of oxidative stress in the presence of 7-NI
and S-MT was no different from the activity of oxidative
stress in the group given 7-MI only, while activity in the
later period was lower than in groups given 7-NI and S-MT
only. The non-selective NO synthase inhibitor L-NAME,
contrary to our expectations, had no protective effects,
which included the absence of any effects on the extent of
lipid peroxidation and decreases in the concentrations of
antioxidant protective factors in brain tissue at both periods
of brain ischemia/reperfusion. L-NAME, unlike 7-NI, irre-
versibly inhibits the constitutional (neuronal and endothe-
lial) isoforms of NO synthase and reversibly inhibits
inducible NO synthase. Analysis of measures of the proox-
idant-antioxidant state in groups given 7-NI and L-NAME
provided grounds for suggesting that NO formed by
endothelial NO synthase has antioxidant effects.
The mechanism of the antioxidant action of NO
involves its ability to operate as a radical trap, facilitating
the removal of radicals and reductions in their toxicity
[21]. The antioxidant action of NO in vessel walls is medi-
ated by inhibition of lipoxygenase-dependent lipid and
lipoprotein oxidation [9, 21]. In neurons, this results from
suppression of NMDA receptor activity of neurons, which
in conditions of L-arginine deficiency may also result in
the increased formation of oxygen radicals [9, 19]. In addi-
tion, NO can limit oxidative damage by modulating cellu-
lar and physiological processes [2, 22]. Correction of the
L-arginine-NO system induces a shift in the prooxidant-
antioxidant equilibrium, apparently associated not only
with potentially high levels able to react with the multitude
of target molecules responsible for the development of
oxidative stress, but also with decreases in the contribu-
tions of other factors to the antioxidant potential of the
body, particularly changes in the oxygen affinity of
hemoglobin [3].
In addition, the antioxidant effects of NO formed by
endothelial NO synthase may be associated with its ability
to enhance the perfusion of brain tissues via NO-dependent
dilation of vessels [10]. NO decreases the activity of oxida-
tive processes by leukocytes sequestered in the vessels and
tissues of the reperfused organ, which is associated with its
antiadhesive properties [20]. The greatest antioxidant effect
was seen in the group given both selective NO synthase
inhibitors and L-arginine, which can be regarded as a result
of suppression of the prooxidant effects of NO formed by
neuronal and inducible NO synthase and increases in the
antioxidant effects of NO of endothelial origin.
Thus, complex analysis of the separate and combined
use of selective and non-selective inhibitors along with
L-arginine provides grounds for considering that NO is
involved in the activation of oxidative processes in brain tis-
sue at both periods of brain ischemia/reperfusion. However,
the roles of NO formed by the various isoforms of NO syn-
thases are different: activation of oxidative processes at both
periods of brain ischemia/reperfusion is associated with
hyperactivation of the neuronal isoform of NO synthase and
in the later period with increased activity of the inducible
NO synthase isoform.
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